Press Releases
Feb. 25, 2026
Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk
Neutral
Broad Institute of MIT and Harvard
Owner: Broad institute (Non-profit)
Feb. 25, 2026
Of Skin and Wellness Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
Neutral
EIN Presswire
Feb. 24, 2026
Healthcare Cloud Computing Market Size to Worth USD 312.97 Billion by 2035
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
European Carbon Farming Summit 2026 — From Pilots to Implementation
Neutral
EIN Presswire
Feb. 23, 2026
COSMAX Establishes First European Production Base with Strategic Acquisition of Italy’s Keminova
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
Menstrual Health Apps Market’s 20.28% CAGR Reflects Strong Investor Confidence in Women-Centric Innovation
Indeterminate
GlobeNewswire, Inc.
Feb. 25, 2026
SIP Health & Wealth Summit, 24 March 2026, Fairmont Monte Carlo, Monaco - Early Bird Rate Ends Soon
Neutral
EIN Presswire
Feb. 23, 2026
Organic Fertilizer Market Set to Surge to USD 15.6 Billion by 2033 on Sustainable Agriculture Boom | Study by Market Minds
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Growing Number of Americans in Germany Highlights Ongoing US Tax Obligations Abroad
Neutral
EIN Presswire
Feb. 24, 2026
Premium Organic Travel Neck Pillow Debuts with Ergonomic Innovation
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Auction of Pristine 27-Meter Ferretti Custom Line Navetta Yacht in Italy
Neutral
EIN Presswire
Feb. 24, 2026
ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia
Indeterminate
GlobeNewswire, Inc.